James Singleton is General Counsel (US) for Waypoint Capital, which focuses on investments in the healthcare and life science sectors, and asset management in private equity, hedge funds, real estate and fund-of-funds investments. James also serves as General Counsel for Waypoint’s affiliate Gurnet Point Capital, a global healthcare fund focused on the healthcare and life sciences sectors. Prior to joining Waypoint in 2016, James worked in Geneva, Switzerland for 12 years for Serono International (NYSE: SRA) and its successor Merck Serono, most recently as Head of Legal for Merck Ventures, Merck’s corporate venture fund, and Head of Legal for Merck Biopharma Global Business Development.
James has over 20 years of experience in the biopharmaceutical industry, with a focus on licensing, commercial and R&D collaborations and strategic alliances, venture capital investments, M&A and general corporate and governance matters.
James received his Juris Doctor degree from NYU School of Law and his B.A. from SUNY at Albany.